These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 24721346)
1. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer]. Peng F; Zhou J; Sheng W; Zhang D; Dong M Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):90-5. PubMed ID: 24721346 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological significance of the expression of carbonic anhydrase I and II in human pancreatic cancer]. Sheng WW; Dong M; Zhou JP; Kong FM; Li YJ Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3407-11. PubMed ID: 23327700 [TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220 [TBL] [Abstract][Full Text] [Related]
4. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer]. Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological significance of the expression of calreticulin in human pancreatic cancer]. Sheng WW; Dong M; Zhou JP; Li X; Dong Q Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):58-61. PubMed ID: 23578430 [TBL] [Abstract][Full Text] [Related]
6. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer]. Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma]. Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650 [No Abstract] [Full Text] [Related]
8. [Clinicopathological significance of the expression of carbonic anhydrase II in human pancreatic invasive ductal cancer]. Sheng WW; Zhou JP; Kong FM; Li YJ; Dong M Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):728-31. PubMed ID: 23157907 [TBL] [Abstract][Full Text] [Related]
9. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532 [TBL] [Abstract][Full Text] [Related]
10. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504 [TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
13. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077 [TBL] [Abstract][Full Text] [Related]
14. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis. Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047 [TBL] [Abstract][Full Text] [Related]
15. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Giannuzzo A; Pedersen SF; Novak I Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222 [TBL] [Abstract][Full Text] [Related]
16. Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters. Wu W; Zhang J; Zhou L; You L; Zhao Y; Li J Sci China Life Sci; 2012 Sep; 55(9):747-52. PubMed ID: 23015122 [TBL] [Abstract][Full Text] [Related]
17. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627 [TBL] [Abstract][Full Text] [Related]
18. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. Bressy C; Lac S; Nigri J; Leca J; Roques J; Lavaut MN; Secq V; Guillaumond F; Bui TT; Pietrasz D; Granjeaud S; Bachet JB; Ouaissi M; Iovanna J; Vasseur S; Tomasini R Cancer Res; 2018 Feb; 78(4):909-921. PubMed ID: 29269518 [TBL] [Abstract][Full Text] [Related]
19. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma. Liu QH; Shi ML; Bai J; Zheng JN Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]